New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Alcatel Lucent SA (ADR) (NYSE:ALU), North American Palladium Ltd (USA) (NYSEMKT:PAL), DARA Biosciences Inc (NASDAQ:DARA), Flextronics International Ltd (NASDAQ:FLEX)
Alcatel Lucent SA (ADR) (NYSE:ALU) the stock opened the session at $4.49 but then moved to $4.51. At that price, the stock showed a negative performance of -0.22%. Alcatel Lucent SA is a France based company that proposes solutions used by service providers, businesses, and governments worldwide to offer voice, data, and video services to their own customers. It is also engaged in mobile, fixed, Internet Protocol (IP) and optics technologies, applications and services.
Will ALU Get Buyers Even After The Recent Rally? Find Out Here
North American Palladium Ltd (USA) (NYSEMKT:PAL) opened the session at $0.44 and closed the session at $0.453. The stock showed a positive performance of 3.40% in previous trading session. North American Palladium Ltd. (NAP) is a precious metals producer that has been operating its flagship Lac des Iles mine (LDI) located in Ontario, Canada. LDI is a primary producer of palladium. The Company is in the business of exploring and mining palladium, platinum, gold and certain base metals. The Company’s 100%-owned subsidiary is the Lac des Iles Mines Ltd. (LDI).
For How Long PAL will fight for Profitability? Read This Trend Analysis report
DARA Biosciences Inc (NASDAQ:DARA) opened the session at $0.51 and closed the session at $0.590. The stock showed a positive performance of 0.01% in previous trading session. The beta of the stock remained 1.49. DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. The Company has the exclusive United States marketing rights to its Soltamox (oral liquid tamoxifen). Why Should Investors Buy DARA After The Recent Gain? Just Go Here and Find Out
Flextronics International Ltd (NASDAQ:FLEX) traded with volume of 6.59 million shares in the prior session and the average volume of the stock remained 5.34 million shares. The beta of the stock remained 1.92. Flextronics International Ltd. (Flextronics) is a global provider of global supply chain solutions, through which the Company designs, build, ship and services a packaged electronic product to original equipment manufacturers (OEMs) in the markets, which include High Reliability Solutions (HRS),
Is FLEX a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)